We studied the effects of M. tuberculosis secretory proteins ESAT-6 and CFP-10 on the properties of vaccinal mycobacteria BCG not producing these proteins. Phagocytosis of M. bovis by macrophages, proliferation of mycobacteria in macrophages, apoptosis and necrosis of macrophages, and the production of reactive oxygen and nitrogen species were studied. It was shown that both ESAT-6 and CFP-10 significantly increased the number of phagocytized mycobacteria by increasing the number of phagocytic-active macrophages and augment the intracellular proliferation of the pathogen. At the same time, macrophages preincubated with ESAT-6 and CFP-10 reduce the production of reactive oxygen and nitrogen species and are more susceptible to apoptosis and necrosis in the presence of mycobacteria. In summary, these proteins suppress macrophage-mediated mechanisms of anti-tuberculosis resistance and impart pronounced pathogenic properties to non-pathogenic mycobacteria that do not secrete ESAT-6 and CFP-10.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Belogorodtsev SN, Shvarts YS, Krasnov VA. Patent RU No. 2702609. Method for simulating tuberculosis infection in vitro. Bull. No. 28. Published October 8, 2019.
Abebe F, Belay M, Legesse M, Mihret A, Franken KS. Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting. Clin. Exp. Immunol. 2017;189(2):241-249. https://doi.org/10.1111/cei.1297
Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85BESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Vaccine. 2009;27(1):28-37. https://doi.org/10.1016/j.vaccine.2008.10.034
Ganguly N, Siddiqui I, Sharma P. Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence. Tuberculosis (Edinb). 2008;88(6):510-517. https://doi.org/10.1016/j.tube.2008.05.002
Hemmati M, Seghatoleslam A, Rasti M, Ebadat S, Mosavari N, Habibagahi M, Taheri M, Sardarian AR, Mostafavi-Pour Z. Expression and purification of recombinant Mycobacterium tuberculosis (TB) antigens, ESAT-6, CFP-10 and ESAT- 6/CFP-10 and their diagnosis potential for detection of TB patients. Iran. Red Crescent. Med. J. 2011;13(8):556-563.
Hill PC, Jackson-Sillah D, Fox A, Franken KL, Lugos MD, Jeffries DJ, Donkor SA, Hammond AS, Adegbola RA, Ottenhoff TH, Klein MR, Brookes RH. ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia. J. Clin. Microbiol. 2005;43(5):2070-2074. https://doi.org/10.1128/JCM.43.5.2070-2074.2005
Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, Morin PM, Marks CB, Padiyar J, Goulding C, Gingery M, Eisenberg D, Russell RG, Derrick SC, Collins FM, Morris SL, King CH, Jacobs WR Jr. The primary mechanism of attenuation of bacillus Calmette—Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl Acad. Sci. USA. 2003;100(21):12420-12425. https://doi.org/10.1073/pnas.1635213100
Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, Behr MA, Sherman DR. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette—Guérin attenuation. J. Infect.Dis. 2003;187(1):117-123. https://doi.org/10.1086/345862
Luo Y, Han R, Evanoff DP, Chen X. Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette—Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells. Clin. Exp. Immunol. 2010;160(3):359-368. https://doi.org/10.1111/j.1365-2249.2010.04105.x
Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 2002;46(3):709-717. https://doi.org/10.1046/j.1365-2958.2002.03237.x
Rodriguez DC, Ocampo M, Salazar LM, Patarroyo MA. Quantifying intracellular Mycobacterium tuberculosis: An essential issue for in vitro assays. Microbiologyopen. 2018;7(2):e00588. https://doi.org/10.1002/mbo3.588
Sassetti CM, Rubin EJ. Genetic requirements for mycobacterial survival during infection. Proc. Natl Acad. Sci. USA. 2003;100(22):12989-12994. https://doi.org/10.1073/pnas.2134250100
Trovero A, Argüelles C, Cataldi A. Preparation of a working seed lot of BCG and quality control by PCR genotyping. Rev. Argent. Microbiol. 2010;42(1):4-10. https://doi.org/10.1590/S0325-75412010000100002
Wang X, Barnes PF, Huang F, Alvarez IB, Neuenschwander PF, Sherman DR, Samten B. Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses. J. Immunol. 2012;189(6):3092-3103. https://doi.org/10.4049/jimmunol.1200573
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 5, pp. 633-638, May, 2021
Rights and permissions
About this article
Cite this article
Belogorodtsev, S.N., Nemkova, E.K., Stavitskaya, N.V. et al. Pathogenic Effects of M. tuberculosis-Specific Proteins ESAT-6 and CFP-10 in Macrophage Culture and in 3D-Granulemogenesis Model In Vitro. Bull Exp Biol Med 171, 656–660 (2021). https://doi.org/10.1007/s10517-021-05288-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05288-z